Abstract
Human fungal infections have significantly increased in recent years particularly in immunocompromised hosts. Candidiasis is one of them. The emergence of new virulence factors and drug resistance in its aetiological agent Candida spp. beckons the need for new drug discoveries, as the present-day drugs are insufficient in combating the disease. Therapeutic alternatives can be the medicinal plants and phytocompounds, which have been in traditional system of medicine for their empirical antifungal properties. They could be reliable alternatives to overcome the disadvantages of antifungal drugs that include undesirable side effects, toxicity, recurrence, drug-drug interactions, and multiple drug resistance. The present article reviews the anticandidal activity of different medicinal plants and phytochemicals under the major classes of secondary metabolites such as phenolics, alkaloids, terpenoids, saponins, flavonoids, proteins, and peptides.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Leroy O, Gangneux JP, Montravers P et al (2009) Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005–2006). Crit Care Med 37:1612–1618
Vincent JL, Rello J, Marshall JE et al (2009) International study of the prevalence and outcomes of infection in intensive care units. JAMA 302:2323–2329
Pfaller MA, Diekema DJ (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20:133–163
Prieto D, Correia I, Pla J et al (2016) Adaptation of Candida albicans to commensalism in the gut. Future Microbiol 11:567–583
Arendrup MC, Fuursted K, Gahrn-Hansen B et al (2008) Semi-national surveillance of fungaemia in Denmark 2004-2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility. Clin Microbiol Infect 14:487–494
Arendrup MC, Fuursted K, Gahrn-Hansen B et al (2005) Semi national surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility. J Clin Microbiol 43:4434–4440
Arendrup MC (2014) Update on antifungal resistance in Aspergillus and Candida. Clin Microbiol Infect 20(6):42–48
Borg-von Zepelin M, Meyer I, Thomssen R et al (1999) HIV-Protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases. J Invest Dermatol 113:747–751
Kim J, Sudbery P (2011) Candida albicans, a major human fungal pathogen. J Microbiol 49:171–177
Brunke S, Hube B (2013) Two unlike cousins: Candida albicans and Candida glabrata infection strategies. Cell Microbiol 15:701–708
Ferreira AV, Prado CG, Carvalho RR et al (2013) Candida albicans and non-C. albicans Candida species: comparison of biofilm production and metabolic activity in biofilms, and putative virulence properties of isolates from hospital environments and infections. Mycopathologia 175:265–272
Mayer FL, Wilson D, Hube B (2013) Candida albicans pathogenicity mechanisms. Virulence 4:119–128
Sardi JCO, Scorzoni L, Bernardi T et al (2013) Candida species: current epidemiology, pathogenicity, biofilm formation natural antifungal products and new therapeutic options. J Med Microbiol 62:10–24
Calderone RA, Fonzi WA (2001) Virulence factors of Candida albicans. Trends Microbiol 9:327–355
Hube B (2004) From commensal to pathogen: stage- and tissue-specific gene expression of Candida albicans. Curr Opin Microbiol 7:336–341
Gullo FP, Sardi JCO, Santos VAFFM et al (2012) Antifungal activity of maytenin and pristimirin. J Evid Based Complement Altern Med 2012:1–6
Henriques M, Azeredo J, Oliveira R (2006) Candida albicans and Candida dubliniensis: comparison of biofilm formation in terms of biomass and activity. Br J Biomed Sci 63:5–11
Kamba AS, Hassan LG (2010) Phytochemical screening and antimicrobial activities of Euphorbia balsamifera leaves, stems and roots against some pathogenic microorganisms. Af J Pharm Pharmacol 4:645–652
Toure A, Bahi C, Ouattara K et al (2011) Phytochemical screening and in vitro antifungal activities of extracts of leaves of Morinda morindoides (Morinda, Rubiaceae). J Med Plants Res 5:6780–6786
Chojnacka EBML, Staniszewska M (2015) Tetrazole activity against Candida albicans. The role of KEX2 mutations in the sensitivity to (±)-1-[5-(2-chlorophenyl)-2H-tetrazol- 2-yl] propan-2-yl acetate. Bioorg Med Chem Lett 25:2657–2663
Pfaller MA, Diekema DJ, Sheehan DJ (2006) Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing. Clin Microbiol Rev 19:435–447
Grant SM, Clissold SP (1990) Fluconazole: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs 39:877–916
Sanguinetti M, Posteraro B, Lass-Florl C (2015) Antifungal drug resistance among Candida species: Mechanisms and clinical impact. Mycoses 5:2–13
White TC, Holleman S, Dy F et al (2002) Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother 46:1704–1713
Shokri H (2014) Genotypic variation and antifungal susceptibly of Candida zeylanoides clinical isolates. J Mycol Med 24:179–184
Grasela TH, Goodwin SD, Walawander MK (1990) Prospective surveillance of intravenous amphotericin B use patterns. Pharmacotherapy 10:341–348
Fanos V, Cataldi L (2000) Amphotericin B-induced nephrotoxicity: a review. J Chemother 12:463–470
Agarwal S, Thakur K, Kanga A et al (2008) Catheter-related candidemia caused by Candida lipolytica in a child with tubercular meningitis. Ind J Pathol Microbiol 51:298–300
Lupan L, Bandula R, Vasilescu M et al (1996) Spectroscopic study on nystatin conformation modification generated by its interaction with the solvent. J Anal Chem 355:409–411
Koehn FE, Carter GT (2005) The evolving role of natural products in drug discovery. Nat Rev Drug Discov 4:206–220
Meng JC, Hu YF, Chen JH et al (2001) Antifungal highly oxygenated guaianolides and other constituents from Ajania fruticulosa. Phytochemistry 58:1141–1145
Lavault M, Landreau A, Larcher G et al (2005) Antileishmanial and antifungal activities of xanthanolides isolated from Xanthium macrocarpum. Fitoterapia 76:363–366
Sabanero M, Quijano L, Rios T et al (1995) Encelin: a fungal growth inhibitor. Planta Med 61:185–186
Starks CM, Williams RB, Goering MG et al (2010) Antibacterial clerodane diterpenes from Goldenrod (Solidago virgaurea). Phytochemistry 71:104–109
Renault S, De Lucca AJ, Boue S et al (2003) CAY-I, a novel antifungal compound from cayenne pepper. Med Mycol 41:75–82
Du Z, Zhu N, Ze-Ren-Wang-Mu N et al (2003) Two new antifungal saponins from the Tibetan herbal medicine Clematis tangutica. Planta Med 69:547–551
Plaza A, Cinco M, Tubaro A et al (2003) New triterpene glycosides from the stems of Anomospermum grandifolium. J Nat Prod 66:1606–1610
Sauton M, Mitaine AC, Miyamoto T et al (2004) A new steroidal saponin from Dioscorea cayenensis. Chem Pharm Bull 52:1353–1355
Pistelli L, Bertoli A, Lepori E et al (2002) Antimicrobial and antifungal activity of crude extracts and isolated saponins from Astragalus verrucosus. Fitoterapia 73:336–339
Mandal P, Sinha SP, Mandal NC (2005) Antimicrobial activity of saponins from Acacia auriculiformis. Fitoterapia 76:462–465
Mel’nichenko EG, Kirsanova MA, Grishkovets VI et al (2003) Antimicrobial activity of saponins from Hedera taurica Carr. Mikrobiol Z 65:8–12
Zamilpa A, Tortoriello J, Navarro V et al (2002) Five new steroidal saponins from Solanum chrysotrichum leaves and their antimycotic activity. J Nat Prod 65:1815–1819
Bedir E, Khan IA, Walker LA (2002) Biologically active steroidal glycosides from Tribulus terrestris. Pharmazie 57:491–493
Zhang JD, Xu Z, Cao YB et al (2006) Antifungal activities and action mechanisms of compounds from Tribulus terrestris L. J Ethnopharmacol 103:76–84
Zhang JD, Cao YB, Xu Z et al (2005) In vitro and in vivo antifungal activities of the eight steroid saponins from Tribulus terrestris L. with potent activity against fluconazole-resistant fungal pathogens. Biol Pharm Bull 28:2211–2215
Kumar M, Sarma P, Dkhar MS et al (2017) Assessment of chemically characterised Gaultheria fragrantissima Wall. essential oil and its major component as safe plant based preservative for millets against fungal, aflatoxin contamination and lipid peroxidation during storage. J Food Sci Technol 55:111–119
Lee DG, Park Y, Kim MR et al (2004) Anti-fungal effects of phenolic amides isolated from the root bark of Lycium chinense. Biotechnol Lett 26:1125–1130
Naldoni FJ, Claudino AL, Cruz JW Jr et al (2009) Antimicrobial activity of benzophenones and extracts from the fruits of Garcinia brasiliensis. J Med Food 12:403–407
De Leo M, Braca A, De Tomasi N et al (2004) Phenolic compounds from Baseonema acuminatum leaves: isolation and antimicrobial activity. Planta Med 70:841–846
Andrae-Marobela K, Ghislain FW, Okatch H et al (2013) Polyphenols: a diverse class of multi-target anti-HIV-1 agents. Curr Drug Metab 14:392–413
Cowan MM (1999) Plant products as antimicrobial agents. Clin Microbiol Rev 12:564–582
Yigit D, Yigit N, Mavi A (2009) Antioxidant and antimicrobial activities of bitter and sweet apricot (Prunus armeniaca L.) kernels. Braz J Med Biol Res 42:346–352
Alcerito T, Barbo FE, Negri G et al (2002) Foliar epicuticular wax of Arrabidaea brachypoda: flavonoids and antifungal activity. Biochem Syst Ecol 30:677–683
Sohn HY, Son KH, Kwon CS et al (2004) Antimicrobial and cytotoxic activity of 18 prenylated flavonoids isolated from medicinal plants: Morus alba L., Morus mongolica Schneider, Broussnetia papyrifera (L.) Vent, Sophora flavescens Ait and Echinosophora koreensis Nakai. Phytomedicine 11:666–672
Ragasa CY, Co AL, Rideout JA (2005) Antifungal metabolites from Blumea balsamifera. Nat Prod Res 19:231–237
Rao MS, Duddeck H, Dembinski R (2002) Isolation and structural elucidation of 3,4′,5,7-tetraacetyl quercetin from Adina cordifolia (Karam ki Gaach). Fitoterapia 73:353–355
Lalla RV, Patton LL, Dongari-Bagtzoglou A (2013) Oral candidiasis: pathogenesis, clinical presentation, diagnosis and treatment strategies. J Calif Dental Assoc 41:263–268
Serpa R, Franca EJ, Furlaneto-Maia L et al (2012) In vitro antifungal activity of the flavonoid baicalein against Candida species. J Med Microbiol 61:1704–1708
Herrera CL, Alvear M, Barrientos L et al (2010) The antifungal effect of six commercial extracts of Chilean propolis on Candida spp. Ciencia E Invest Agraria 37:75–84
Yousefbeyk F, Gohari AR, Hashemighahderijani Z et al (2014) Bioactive terpenoids and flavonoids from Daucus littoralis Smith subsp. hyrcanicus Rech. f, an endemic species of Iran. DARU J Pharmaceu Sci 22:12
Wachter GA, Hoffmann JJ, Furbacher T et al (1999) Antibacterial and antifungal flavanones from Eysenhardtia texana. Phytochemistry 52:1469–1471
Agnihotri VJK, ElSohly HN, Khan SI et al (2008) Constituents of Nelumbo nucifera leaves and their antimalarial and antifungal activity. Phytochem Lett 1:89–93
Aguero MB, Svetaz L, Baroni V et al (2014) Urban propolis from San Juan province (Argentina): Ethnopharmacological uses and antifungal activity against Candida and dermatophytes. Ind Crops Prod 57:166–173
Liu W, Li LP, Zhang JD et al (2014) Synergistic antifungal effect of glabridin and fluconazole. PLoS one 9:pe103442
Greathouse GA, Walkins GH (1938) Berberine as a factor in the resistance of Mahonia trifoliate and M. swaseya to Phymatotrichum root-rot. Am J Bot 25:743–748
Freile M, Giannini M, Sortino M et al (2006) Antifungal activity of aqueous extracts and of Berberine isolated from Berberis heterophylla. Acta Farm Bona 25:83–88
Dabur R, Chhillar AK, Yadav V et al (2005) In vitro antifungal activity of 2-(3,4-dimethyl-2,5-dihydro-1H-pyrrol-2-yl)-1-methylethyl pentanoate, a dihydro–pyrrole derivative. J Med Microbiol 54:549–552
SlobodnÃková L, Kost’álová D, Labudová D et al (2004) Antimicrobial activity of Mahonia aquifolium crude extract and its major isolated alkaloids. Phytother Res 18:674–676
Bonvicini F, Antognoni F, Iannello C et al (2014) Relevant and selective activity of Pancratium illyricum L. against Candida albicans clinical isolates: a combined effect on yeast growth and virulence. BMC Complement Altern Med 14:409
Klausmeyer P, Chmurny GN, McCloud TG et al (2004) A novel antimicrobial indolizinium alkaloid from Aniba panurensis. J Nat Prod 67:1732–1735
Park Y, Choi BH, Kwak JS et al (2005) Kunitz-type serine protease inhibitor from potato (Solanum tuberosum L. cv. Jopung). J Agric Food Chem 53:6491–6496
Giordani R, Regli P, Kaloustian J et al (2004) Antifungal effect of various essential oils against Candida albicans. Potentiation of antifungal action of amphotericin B by essential oil from Thymus vulgaris. Phytother Res 18:990–995
Nakamura CV, Ishida K, Faccin LC et al (2004) In vitro activity of essential oil from Ocimum gratissimum L. against four Candida species. Res Microbiol 155:579–586
Salgueiro LR, Piato E, Goncalves MJ et al (2004) Active antifungal substances from natural resources. Planta Med 70:572–575
Cavaleiro C, Pinto E, Goncalves MJ et al (2006) Antifungal activity of Juniperus essential oils against dermatophyte, Aspergillus and Candida strains. J Appl Microbiol 100:1333–1338
Hamza OJM, Beukel CJPB, Matee MIN et al (2006) Antifungal activity of some Tanzanian plants used traditionally for the treatment of fungal infections. J Ethnopharmacol 108:124–132
Braga FG, Bouzada MLM, Fabri RL et al (2007) Antileishmanial and antifungal activity of plants used in traditional medicine in Brazil. J Ethnopharmacol 111:396–402
Krisch J, Ordogh L, Galgoczy L et al (2009) Anticandidal effect of berry juices and extracts from Ribes species. Cent Eur J Biol 4:86–89
Bernardes I, Felipe Rodrigues MP, Bacelli GK et al (2012) Aloe vera extract reduces both growth and germ tube formation by Candida albicans. Mycoses 55:257–261
Al Bagieh NH, Idowu A, Salako NO (1994) Effect of aqueous extract of miswak on the in vitro growth of Candida albicans. Microbios 80:107–113
Aqil F, Zahin M, Ahmad I (2010) Antifungal activity of medicinal plant extracts and phytocompounds: a review. In: Ahmad I et al (eds) Combating fungal infections. Springer, Berlin/Heidelberg, pp 449–484
Sharanappa R, Vidyasagar GM (2013) Anti-candida activity of medicinal plants: a review. Inter J Pharm Pharm Sci 5:9–16
Rathod T, Padalia H, Chanda S (2015) The potential of plant extracts against multidrug resistant Candida species – a review. In: Mendez-Vilas A (ed) The battle against microbial pathogens: basic science, technological advances and educational programs, pp 246–256
Seleem D, Pardi V, Murata RM (2017) Review of flavonoids: a diverse group of natural compounds with anti- Candida albicans activity in vitro. Arch Oral Biol 76:76–83
Katoch M, Salgotra A, Singh G (2014) Endophytic fungi found in association with Bacopa monnieri as potential producers of industrial enzymes and antimicrobial bioactive compounds. Braz Arch Biol Technol 57:714–722
Sharma D, Roy V, Saraf A (2017) An update on phytochemicals analysis and medicinal prospects of Indian herb Withania somnifera. Ambient Sci 4:1–6
Williamson EM (2001) Synergy and other interactions in phytomedicines. Phytomedicine 8:401–409
Rakholiya K, Chanda S (2012) In vitro interaction of certain antimicrobial agent in combination with plant extracts against some pathogenic bacterial strains. Asian Pac J Trop Biomed 2:S1466–S1470
Nahrstedt A, Butterweck V (2010) Lessons learned from herbal medicinal products: the example of St. John’s wort. J Nat Prod 73:1015–1021
Wagner H, Merzenich GU (2009) Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine 16:97–110
Chanda S, Rakholiya K, Dholakia K et al (2013) Antimicrobial, antioxidant and synergistic properties of two nutraceutical plants: Terminalia catappa L. and Colocasia esculenta L. Turk J Biol 37:81–91
Avijgan M, Mahboubi M, Nasab MM et al (2014) Synergistic activity between Echinophora platyloba DC ethanolic extract and azole drugs against clinical isolates of Candida albicans from women suffering chronic recurrent vaginitis. J de Mycol Med 24:112–116
Santos KKA, Matias EFF, Sobral-Souza CE et al (2013) Trypanocide, cytotoxic, and anti-candida activities of natural products: Hyptis martiusii Benth. Eur J Integr Med 5:427–431
Castano VT, Royero JC, Londono BZ et al (2011) Anti-Candida albicans activity, cytotoxicity and interaction with antifungal drugs of essential oils and extracts from aromatic and medicinal plants. Asocia Colom De Infectol 15:160–167
Wagner H (2006) Multitarget therapy–the future of treatment for more than just functional dyspepsia. Phytomedicine 13:122–129
Pankey G, Ashcraft D, Patel N (2005) In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin. Antimicrob Agents Chemother 49:5166–5168
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Raghuwanshi, R. (2019). Phytochemicals: New Avenues in Anticandidal Activity. In: Singh, K., Srivastava, N. (eds) Recent Trends in Human and Animal Mycology. Springer, Singapore. https://doi.org/10.1007/978-981-13-9435-5_9
Download citation
DOI: https://doi.org/10.1007/978-981-13-9435-5_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-9434-8
Online ISBN: 978-981-13-9435-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)